However, when GLP-1 are used in combination with other hypoglycemic drugs such as insulin, sulfonylureas, etc., the risk of hypoglycemia may increase
Fatani SH
20 Feb 2026 Few GLP 1 Studies Report Dietary Outcomes A review of 41 trials finds only two assessed dietary intake with GLP 1 receptor agonists, underscoring a critical gap in nutrition research
Lee Jun H, Budanov Andrei V, Karin M
We remind hospitals that we review, on an annual basis, the APC assignments for all items and services paid under the OPPS and we will continue to monitor the claims data as they become available
While researchers are still gathering data about the weight loss benefits of both drugs, Tirzepatide is likely a more effective weight loss injection for some people